Inventurus Knowledge Solutions Limited IKS
NSE · India · Commercial Services
INR 1,776.40+28.90 (+1.65%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
DALLAS, September 10, 2026--IKS Health, a global leader in care enablement solutions supporting clinical, administrative, and financial efficiencies across the patient journey, today announced the appointment of Amaris McComas as Group Chief Human Resources Officer (CHRO). McComas joins the company from TruBridge, Inc., acquired by IKS Health in July 2026, and is now a part of the executive leadership team of the company.
Inventurus Knowledge Solutions Ltd (NSE:IKS) reports 21% YoY revenue growth and outlines a clear path to INR3,000 crores EBITDA by FY30 through AI innovation and disciplined M&A.
TruBridge (NASDAQ:TBRG) stockholders approved the company’s proposed merger agreement under which TruBridge will become a subsidiary of Inventurus Knowledge Solutions Inc., or IKS, during a virtual special meeting held July 7, 2026. Glenn Tobin, TruBridge’s Chairman of the Board, opened the meeting
DALLAS & MOBILE, Ala., July 09, 2026--IKS Health, a global leader in care enablement solutions across the patient journey, today announced the successful completion of its previously announced acquisition of TruBridge™, Inc. TruBridge is a prominent provider of healthcare technology including an electronic health record (EHR) and revenue cycle management solutions for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health.
TruBridge climbs after Q1 EPS beats estimates and an IKS Health buyout deal sets a $26.25-per-share cash offer for shareholders.
Inventurus Knowledge Solutions Ltd (NSE:IKS) reports impressive 18.5% revenue growth, strategic acquisitions, and AI advancements, while addressing challenges in AI integration and market competition.
Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of its strategic collaboration with IKS Health, a global leader in care enablement solutions. Through this enhanced partnership, IKS Health will use Certilytics' GenAI-powered predictive intelligence and real-time decision support to modernize administrative operations, enhance member engagement and improve price transparency.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.